Back to results
US 12,703,866 B2Granted
Engineered microorganisms
AssigneeSynlogic Operating Company, Inc.
InventorsMichael James, Aida Kalantari, Tea Mirabella, Lauren Renaud, Lee Kristensen, Vincent Isabella
Life of this patent
Estimating the term…
Abstract
The present invention relates to engineered microorganisms, wherein the engineered microorganisms comprise a therapeutic molecule and a modified pks island.
Claims16
An engineered bacterium comprising one or more gene(s) or gene cassette(s) encoding a therapeutic molecule and a modified pks island as compared to a corresponding bacterium comprising an unmodified pks island,
- wherein the modified pks island comprises
- 1) a full or partial deletion of the clbA, clbB, clbC, clbD, clbE, clbF, clbG, clbH, clbI, clbJ, clbK, clbL, clbM, clbN, clbO, clbP, clbQ, and clbR gene sequences;
- and
- 2) an intact or unmodified clbS gene sequence;
- and
- 3) a full or partial deletion of the promoter operably linked to clbS;
- wherein the therapeutic molecule is a protein, and
- wherein the engineered bacterium is an engineered Escherichia coli.
5 more elements
Dependencies are inferred from the claim text.